Robert E. Slayton
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 10
- Surgery top 10%
- Testicular diseases and treatments 12
- Bladder and Urothelial Cancer Treatments 3
- Neurology top 10%
- Neuroblastoma Research and Treatments 4
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 4
-
- Cancer therapeutics and mechanisms 4
-
- Prostate Cancer Treatment and Research 4
-
- Cervical Cancer and HPV Research 3
- Co-authors
- Charles P. PerliaArthur H. RossofJohn A. BlessingSteven G. SilverbergHugh M. ShingletonPhilip BonomiWilliam T. CreasmanRobert C. Park
- Partner nations
- United StatesSingapore
In The Last Decade
Robert E. Slayton
36 papers receiving 712 citations
Peers
Comparison fields: 5 of 83
- Reproductive Medicine 222
- Surgery 357
- Neurology 122
- Oncology 213
- Obstetrics and Gynecology 53
Countries citing papers authored by Robert E. Slayton
This map shows the geographic impact of Robert E. Slayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Slayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Slayton more than expected).
Fields of papers citing papers by Robert E. Slayton
This network shows the impact of papers produced by Robert E. Slayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Slayton. The network helps show where Robert E. Slayton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert E. Slayton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 5 | |
| 2 | 1991 | 17 | |
| 3 | 1989 | 5 | |
| 4 | 1988 | 6 | |
| 5 | 1988 | 9 | |
| 6 | 1985 | 20 | |
| 7 | 1985 | 60 | |
| 8 | Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck. | 1984 | 11 |
| 9 | 1983 | 10 | |
| 10 | 1982 | 2 | |
| 11 | 1982 | 2 | |
| 12 | 1981 | 52 | |
| 13 | 1981 | 12 | |
| 14 | Chemotherapy for advanced germinal cell neoplasms: preliminary report of an Eastern Cooperative Oncology Group Study. | 1980 | 8 |
| 15 | 1979 | 1 | |
| 16 | 1978 | 70 | |
| 17 | Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas. | 1978 | 11 |
| 18 | 1971 | 59 | |
| 19 | THE SIGNIFICANCE OF DOUBLY REFRACTILE BODIES IN THE URINE OF PATIENTS WITH DIABETES MELLITUS. | 1964 | 1 |
| 20 | 1955 | 7 |
About Robert E. Slayton
Robert E. Slayton is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 802 indexed citations. Recurring topics across this work include Testicular diseases and treatments (12 papers), Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (4 papers), Neuroblastoma Research and Treatments (4 papers), Cancer therapeutics and mechanisms (4 papers), Prostate Cancer Treatment and Research (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Cervical Cancer and HPV Research (3 papers). The work is most often cited by research in Reproductive Medicine (222 citations), Surgery (357 citations), Neurology (122 citations), Oncology (213 citations) and Obstetrics and Gynecology (53 citations). Robert E. Slayton has collaborated with scholars based in United States and Singapore. Frequent co-authors include Charles P. Perlia, Arthur H. Rossof, John A. Blessing, Steven G. Silverberg, Hugh M. Shingleton, Philip Bonomi, William T. Creasman, Robert C. Park, Paul Elson and Janet Wolter. Their work appears in journals such as Cancer, Gynecologic Oncology, Investigational New Drugs, International Journal of Radiation Oncology*Biology*Physics and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.